| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 06/21/2006 | CN1260227C 5-membered ring heterocyclic compounds with nitrogen |
| 06/21/2006 | CN1260225C Tetrahydropyridino or piperidino hetlrocyclic derivatives |
| 06/21/2006 | CN1259973C Preventives or remedies for psoriasis containing IL-6 antagonist as the active ingredient |
| 06/21/2006 | CN1259965C Medicinal liquor for chimatlon and its preparing process |
| 06/21/2006 | CN1259951C Chinese traditional medicinal preparation for treating acne and whelk |
| 06/21/2006 | CN1259936C Chinese-western combined medicine for treating burn and scald |
| 06/21/2006 | CN1259921C New medicine for treating beriberi |
| 06/21/2006 | CN1259920C Biologically active agents and drugs |
| 06/21/2006 | CN1259919C Sterilizing and bacteria inhibiting pharmaceutical composition and its formulation and preparation process |
| 06/20/2006 | US7064189 Antibodies that immunospecifically bind to trail receptors |
| 06/20/2006 | US7064186 Comprises chemokine polypeptides for diagnosis, prevention and treatment of cell proliferative, immunological and hematopoietic disorders |
| 06/20/2006 | US7064185 Antibody for human Cyr61 |
| 06/20/2006 | US7064147 Amino acids with affinity for the α-2-delta-protein |
| 06/20/2006 | US7064123 substituted acetamides; uses for treating diseases including arthritis, muscular dystrophy, inflammation, tumor invasion, glomerulonephritis, malaria, periodontal disease, and metachromatic leukodystrophy |
| 06/20/2006 | US7064121 benzodiazepine derivatives that may be fused to a pyrroline or piperidine ring; e.g., N-[1 (R)-(3-Aminopropylcarbamoyl)-2-(naphthalen-2-yl)ethyl]-3-(5,11-dioxo-2,3-dihydro-1H-(11aS)-pyrrolo[2,1-c][1,4]benzodiazepin-10-yl)propionamide; increasing levels of endogenous growth hormones in humans and animals |
| 06/20/2006 | US7064115 (20S)-1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses |
| 06/20/2006 | US7063964 Nucleic acids encoding IL-12 antibody |
| 06/20/2006 | CA2354770C Compositions with enhanced photoprotective effect and method for using same |
| 06/15/2006 | WO2006062104A1 Bacillus macroides strain and food using the same |
| 06/15/2006 | WO2006062097A1 Agent for prevention and/or treatment of pruritus |
| 06/15/2006 | WO2006062069A1 REMEDY FOR PRURITUS COMPRISING p38MAP KINASE AS THE ACTIVE INGREDIENT |
| 06/15/2006 | WO2006061446A1 Pharmaceutical compositions |
| 06/15/2006 | WO2006061155A2 Stabilisation of glucocorticoid esters with acids |
| 06/15/2006 | WO2006044379A3 Novel curcumin analogues and uses thereof |
| 06/15/2006 | WO2006042625A3 Compositions with inhibitors of the synthesis of prostaglandin and/or of leukotriene in conjunction with stimulators of the release of cutaneous neuromediators |
| 06/15/2006 | WO2006030241A3 Growth factor treatment for asthma |
| 06/15/2006 | WO2005023176A3 Delivery of physiologixal agents with in-situ gels comprising anionic polysaccharides |
| 06/15/2006 | US20060129209 Method and apparatus for the stimulation of hair growth |
| 06/15/2006 | US20060128810 Remedies for allergic diseases |
| 06/15/2006 | US20060128784 Bis-heteroaryl alkanes as therapeutic agents |
| 06/15/2006 | US20060128780 Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 06/15/2006 | US20060128776 Opioid receptor active compounds |
| 06/15/2006 | US20060128772 2-(2-methoxyphenyl)-3-(2-methoxy-phenyl)-5-phenylamino-(1,2,4)-thiadiazol-2 -ium; metabolic, nervous system and dermatological disorders, antidiabetic; obesity, impaired oral glucose tolerance, type II diabetes and Syndrome X, acne, dry skin and seborrheic dermatitis |
| 06/15/2006 | US20060128749 Compounds |
| 06/15/2006 | US20060128745 Chemical compounds |
| 06/15/2006 | US20060128740 Tricyclic androgen receptor modulator compounds and methods |
| 06/15/2006 | US20060128734 N-(4-(4-(4-hydroxyphenylamino)-pyrimidin-6-yl)-oxyphenyl)-N'-(3-trifluoromethylphenyl)-urea; |
| 06/15/2006 | US20060128674 Induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; antiviral and antitumor agents |
| 06/15/2006 | US20060128659 Sulfotransferase inhibitors |
| 06/15/2006 | US20060128655 Use of hyaluronic acid or its derivatives to enhance delivery of antineoplastic agents |
| 06/15/2006 | US20060128639 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 06/15/2006 | US20060128631 Peptides and derivatives thereof showing cell attachment, spreading and detachment activity |
| 06/15/2006 | US20060128619 Therapeutic use of modulators of notch |
| 06/15/2006 | US20060128013 Directed differentiation of embryonic cells |
| 06/15/2006 | US20060127914 Nicotinic acetylcholine receptor |
| 06/15/2006 | US20060127494 Biologically active products |
| 06/15/2006 | US20060127411 Immune -modulating peptide made of s.aureus enterotoxin b |
| 06/15/2006 | US20060127405 Specifically recognizing human oculospanin and having cytotoxic activity against cancer cells, cancer therapy |
| 06/15/2006 | US20060127395 comprising an E25 anti-IgE antibody and acetic acid ; nasal sprays and slow release formulations drying or freeze-drying; treating an allergic disease |
| 06/15/2006 | US20060127321 Pharmaceutical foam |
| 06/15/2006 | CA2591296A1 Stabilisation of glucocorticoid esters with acids |
| 06/14/2006 | EP1669450A1 Staple type oligonucleotide and drug comprising the same |
| 06/14/2006 | EP1669086A1 Composition comprising TGF-beta and proteins for treating psoriasis |
| 06/14/2006 | EP1669081A1 Apoptotic entities for use in treatment of T-cell-mediated und inflammatory disorders |
| 06/14/2006 | EP1669075A1 Therapeutic agent for ageing macular degeneration |
| 06/14/2006 | EP1668132A1 Cytokine involved in epithelial-mesenchymal transition |
| 06/14/2006 | EP1667674A2 A method of healing skin wounds in mammals and a composition therefor |
| 06/14/2006 | EP1667657A1 Topical aerosol foams |
| 06/14/2006 | EP1515715A4 Hair and nail treatments using alkanolamines |
| 06/14/2006 | EP1497292B1 Azaindolylpiperidine derivatives as antihistaminic and antiallergic agents |
| 06/14/2006 | EP1496951B1 Wound dressings comprising an oxidoreductase enzyme in hydrated condition |
| 06/14/2006 | EP1399439B1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases |
| 06/14/2006 | EP1393075A4 Methods of screening and using inhibitors of angiogenesis |
| 06/14/2006 | EP1381373B1 Medical compositions for use in the treatment or prevention of a functional vitamin b12 deficienfcy |
| 06/14/2006 | EP1372693B1 Peptides for the treatment of wound contracture |
| 06/14/2006 | EP1349836B1 Tetracyclic derivatives as spla2 inhibitors |
| 06/14/2006 | EP1349550B1 Substituted-4-quinolones for the treatment of autoimmune diseases |
| 06/14/2006 | EP1339683B1 Estrogen receptor modulators |
| 06/14/2006 | EP1335701B1 Anti-adiposis topical treatment composition based on garlic bulb extracts |
| 06/14/2006 | EP1289475B1 Water-thin emulsions with low emulsifier levels |
| 06/14/2006 | EP1285661B1 Use of an antioxidant comprising an extract of mozuku |
| 06/14/2006 | EP1261361B1 Oral, nasal and pulmonary dosage formulations of copolymer 1 (glatiramer acetate) |
| 06/14/2006 | EP1214925B1 Chemical peeling agent |
| 06/14/2006 | EP1214324B1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 06/14/2006 | EP1210100B1 Method of treating traumatic brain using non-steroidal anti-inflammatory drugs |
| 06/14/2006 | EP1165085B1 Phthalazine derivatives for treating inflammatory diseases |
| 06/14/2006 | CN1787813A Treatment and/or prevention of non-viral epithelial damage |
| 06/14/2006 | CN1787812A Insoluble globin injectable implant |
| 06/14/2006 | CN1787806A Topical treatment of skin conditions |
| 06/14/2006 | CN1785421A Medicine for preventing kibe |
| 06/14/2006 | CN1785385A Cassia oil composition and its application in making medicine |
| 06/14/2006 | CN1785376A External applied medicine for treating prickly heat |
| 06/14/2006 | CN1785363A Chinese medicinal preparation for treating alopecin and early wbiteness of beard and hair |
| 06/14/2006 | CN1785358A Medicine for treating acne and its preparation method |
| 06/14/2006 | CN1785352A Chinese medicinal preparation for treating acne and preparing process thereof |
| 06/14/2006 | CN1785335A Pure Chinese medicinal preparation for external treating burn and scald |
| 06/14/2006 | CN1785332A Medicine for treating psoriasis and preparing process thereof |
| 06/14/2006 | CN1785311A Capsule for hair blackening |
| 06/14/2006 | CN1785291A Medicine for treating burn and scald and its prepartion method |
| 06/14/2006 | CN1785258A Tea tree oil liposome and its preparation method |
| 06/14/2006 | CN1785257A Tincture for trenting fungus dermatosis |
| 06/14/2006 | CN1785256A External use medicine for treating dermatosis |
| 06/14/2006 | CN1785228A Plaster contg. Chinese herb medicine for treating nose or lip diseases and its prepn. method |
| 06/14/2006 | CN1785215A Black medicine for treating burns and scald |
| 06/14/2006 | CN1785209A Special medicine prescription for treating skin moniliasis |
| 06/14/2006 | CN1785206A Alums bar used for refreshing body naturally and its prepn. method |
| 06/14/2006 | CN1785173A Application of primitive cyanidin in preparing medicine for treating leucoderma |
| 06/14/2006 | CN1785047A Functional health-care food of anti-oxygen lack and anti-free radical and its prepn. method |
| 06/14/2006 | CN1259365C High friction coefficient rubber composite brake shoes |
| 06/14/2006 | CN1259332C C2,5'-disubstituted and N6, C2, 5' trisubstituted adenosine derivatives and their different uses |